FAQs about medical consent & Pfizer-BioNTech booster doses for long-term care residents : a resource for providers participating in the CDC COVID-19 vaccination program, long-term care residents & their families

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.)
• Description:
  In response to inquiries about medical consent surrounding the administration of a booster shot of Pfizer-BioNTech COVID-19 vaccine to residents in long-term care (LTC) settings at least six months after their Pfizer-BioNTech primary series , the Centers for Disease Control and Prevention (CDC) has developed the following responses to frequently asked questions (FAQs).
  
  These FAQs are intended to clarify that medical consent is not required by federal law for COVID-19 vaccination in the United States.
  
  
• Content Notes:
  In response to inquiries about medical consent surrounding the administration of a booster shot of Pfizer-BioNTech COVID-19 vaccine to residents in long-term care (LTC) settings at least six months after their Pfizer-BioNTech primary series1 , the Centers for Disease Control and Prevention (CDC) has developed the following responses to frequently asked questions (FAQs).
• Subjects:
  Coronavirus Infections/prevention &control COVID-19 Vaccines Health Facilities Immunization, Secondary Infection Control Long-Term Care Pandemics Vaccination
• Document Type:
  Webpage
• Name as Subject:
  Pfizer-BioNTech COVID-19 vaccine
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:91d1cfbfb092511b880448697ac867671007b687e49309cdc076fa9767e4e516
• Download URL:
  https://stacks.cdc.gov/view/cdc/110091/cdc_110091_DS1.pdf
• File Type:
  [PDF - 80.72 KB ]